ir.bionanogenomics.com

• charset: utf-8
• name: description content: The Investor Relations website contains information about Bionano Genomics, Inc.'s business for stockholders, potential investors, and financial analysts.
• name: referrer content: no-referrer
• property: og:site_name content: Bionano Genomics, Inc.
• property: og:type content: website
• property: og:url content: https://ir.bionanogenomics.com/investor-relations
• property: og:title content: Investor Relations | Bionano Genomics, Inc.
• property: og:description content: The Investor Relations website contains information about Bionano Genomics, Inc.'s business for stockholders, potential investors, and financial analysts.
• name: Generator content: Drupal 10 (https://www.drupal.org)
• name: MobileOptimized content: width
• name: HandheldFriendly content: true
• name: viewport content: width=device-width, initial-scale=1.0
• class: foundation-mq

• Skip to main navigation
• Overview
• View All Releases
• View All Events
• http://ir.bionanogenomics.com/stock-information/stock-quote-chart
• Tax Information
• Historic Price Lookup
• http://ir.bionanogenomics.com/financial-information/sec-filings
• View All Reports
• Insider Transactions
• Documents & Charters
• Board of Directors
• View All
• Committee Composition
• Responsibility
• http://ir.bionanogenomics.com/investor-resources/investor-contact
• Email Alerts
• RSS Feeds
• http://ir.bionanogenomics.com/#profile
• Corporate Overview
• http://ir.bionanogenomics.com/#
• 2025 BIONANO THIRD QUARTER FINANCIAL RESULTS CALL
• H.C. Wainwright @ Home Event
• H.C. Wainwright 27th Annual Global Investment Conference
• 2025 BIONANO SECOND QUARTER FINANCIAL RESULTS CALL
• 2022 Annual Report
• 2021 Annual Report
• 2020 Annual Report
• 2019 Annual Report
• 2018 Annual Report
• Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
• Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
• Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
• Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
• http://ir.bionanogenomics.com/information-request
• Print Page

• https://bionanogenomics.com/
• Legal Notice
• Privacy Policy

            Domain Name: BIONANOGENOMICS.COM
Registrar: NameCheap, Inc.
Domain Status: client transfer prohibited
Creation Date: 2011-08-11T21:15:32Z
Registry Expiry Date: 2027-08-11T21:15:32Z
Updated Date: 2026-07-12T08:55:35Z
Name Server: DNS1.REGISTRAR-SERVERS.COM
Name Server: DNS2.REGISTRAR-SERVERS.COM
REGISTRAR Contact: NameCheap, Inc.
>>> Last update of RDAP database: 2026-08-09T21:39:03Z         

Техническое SEO

SEO на странице

Контент и UX